Clinical Trials Browser

Phase 2 × Barrett Esophagus × Proflavine × Clear all

NCT02018367 2021-01-14

Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Barrett Esophagus